OKYO Pharma Ltd
OKYO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001849296
In the last 90 days, OKYO Pharma Ltd insiders filed 7 open-market purchases and 0 sales; 19 institutions reported holding it in 13F filings for Q2 2026, worth $9.74M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in OKYO Pharma Ltd as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- +7 vs. Q1 2026
- Shares held
- 6.49M
- +104.0K (+1.6%) vs. Q1 2026
- Total value
- $9.74M
- −$546.9K (−5.3%) vs. Q1 2026
- New holders
- 8
- 3 more added
- Sold out
- 1
- 3 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OKYO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $9.74M |
| Q1 2026 | 12 | $10.3M |
| Q4 2025 | 10 | $1.15M |
| Q3 2025 | 8 | $5.14M |
| Q2 2025 | 5 | $1.48M |
| Q1 2025 | 7 | $2.63M |
| Q4 2024 | 7 | $1.18M |
| Q3 2024 | 6 | $1.02M |
| Q2 2024 | 7 | $1.21M |
| Q1 2024 | 6 | $1.36M |
| Q4 2023 | 7 | $1.51M |
| Q3 2023 | 7 | $176.0K |
| Q2 2023 | 2 | $14.1K |
| Q1 2023 | 1 | $33.3K |
| Q4 2022 | 1 | $14.4K |
| Q3 2022 | 1 | $3.00K |
| Q2 2022 | 3 | $62.0K |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding OKYO Pharma Ltd; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caitong International Asset Management Co., Ltd | 3 | $4 | 0.00% | +3 | New |
| Morgan Stanley | 10 | $15 | 0.00% | 00.0% | Unchanged |
| Continuum Advisory, LLC | 50 | $75 | 0.00% | +50 | New |
| Advisor Group Holdings, Inc. | 152 | $228 | 0.00% | 00.0% | Unchanged |
| EFG International AG | 923 | $1.39K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 6,000 | $9.00K | 0.00% | +6,000 | New |
| Jane Street Group, LLC | 10,302 | $15.5K | 0.00% | +10,302 | New |
| Renaissance Technologies LLC | 11,200 | $16.8K | 0.00% | +11,200 | New |
| Geode Capital Management, LLC | 12,090 | $18.1K | 0.00% | 00.0% | Unchanged |
| Cerity Partners LLC | 12,812 | $19.2K | 0.00% | 00.0% | Unchanged |
| Quantinno Capital Management LP | 33,255 | $49.9K | 0.00% | +33,255 | New |
| RSM US Wealth Management LLC | 33,255 | $49.9K | 0.00% | +33,255 | New |
| XTX Topco Ltd | 37,769 | $56.7K | 0.00% | +117+0.3% | Added |
| UBS Group AG | 55,009 | $82.5K | 0.00% | −4,751−8.0% | Reduced |
| Opaleye Management Inc. | 375,204 | $562.8K | 0.05% | +375,204 | New |
| Balyasny Asset Management LLC | 580,596 | $870.9K | 0.00% | −4,200−0.7% | Reduced |
| Maven Securities LTD | 809,317 | $1.21M | 0.08% | −366,218−31.2% | Reduced |
| Stonepine Capital Management, LLC | 862,996 | $1.29M | 0.99% | +12,996+1.5% | Added |
| Woodline Partners LP | 3,652,768 | $5.48M | 0.02% | +5780.0% | Added |
| Dauntless Investment Group, LLC | 0 | $0 | 0.00% | −3,819−100.0% | Sold out |